u/BallsdeepinTSLA

Reddit r/ValueInvesting
· tracked since Mar 2026
Calls
1
Win Rate
100.0%
return
+28.7%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Best Calls
NVO Long +28.7%
Worst Calls
No live losers yet
Most Mentioned
NVO ×1
Recent Calls
NVO Long 5 months ago
Win Rate 100% Long 1 Short 0
Win Rate
7d 0%
30d 100%
90d 100%
Average Return +28.7% Long Return +28.7% Short Return -
Average Return
7d -0.8%
30d +11.4%
90d +18.9%
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Mar 20
$36.32
+28.7%
NVO trades at a forward P/E of 10 and P/S of 0.56 with a 69% ROE, while securing new FDA approvals (Wegovy HD) and operating in an $86B projected TAM. The market has overreacted to near-term headwinds (competition, guidance), creating a massive disconnect between the $37 share price and the company's intrinsic value (DCF $70-$97). Go long on NVO to capitalize on the extreme valuation mismatch, ongoing $15B buybacks, and upcoming catalysts like the AGM. Pricing pressure, Eli Lilly competition, FDA warning letters, and poor 2026 guidance.
NVO trades at a forward P/E of 10 and P/S of 0.56 with a 69% ROE, while securing new FDA approvals (Wegovy HD) and operating in an $86B projected TAM. The market has overreacted to near-term headwinds (competition, guidance), creating a massive disconnect between the $37 share price and the company's intrinsic value (DCF $70-$97). Go long on NVO to capitalize on the extreme valuation mismatch, ongoing $15B buybacks, and upcoming catalysts like the AGM. Pricing pressure, Eli Lilly competition, FDA warning letters, and poor 2026 guidance.
GLP-1 / Obesity
Showing 1 of 1 calls · sorted by mentions

u/BallsdeepinTSLA has 1 trade ideas tracked on Buzzberg across 1 tickers since March 2026. Most covered: NVO.